Fig. 2

a Computed Tomography (CT) scan in February after treatment with an FGFR inhibitor and a PD-1 inhibitor. b CT scan showing smaller lesions in May 2018 after treatment with Lenvatinib
a Computed Tomography (CT) scan in February after treatment with an FGFR inhibitor and a PD-1 inhibitor. b CT scan showing smaller lesions in May 2018 after treatment with Lenvatinib